In various types of cancerous cell lines (endometrial, ER positive or negative breast cancer cells, seminoma cells...), ERα36 may activate calcium release, the PKC, MAPK/ERK or the PI3K/AKT signaling pathways responsible for cell proliferation, migration and survival [16–18]. This evidence concerns the gene ESR1 and breast carcinoma.